Ranbaxy..Long Term

Pharma major Ranbaxy Laboratories is expected to mop up nearly $2 billion in sales by launching generic versions of four block-buster drugs, including atorvastatin (Lipitor) over the next five-six years.
Details : http://timesofindia.indiatimes.com/...s_from_generic_brands/articleshow/1764345.cms

Regards,
Luckytrader

Hi Lucky,

The long term Weekly chart shows something else is happening.

ss

well i have been tracking ranbaxy since last 6 months, company future looks good but then also stock is not able to hold value at higher levels may be due to recent FDE raids on them or due to overall market crash!?.

I am also interested in investing in ranbaxy at 300 levels and i expect 25% returns in 12 months, do you think it will be possible or we should wait for further correction?

experts please advice.

Oops!
I forgot the chart

Your explanations through charts are fabulous.

Maybe we should wait for good signal before entering.

Regards,
Luckytrader

With the premise that Ranbaxy & Cipla are the two largest pharma cos in India and pharma has good future, I had invested in both during yr 2006. But I was very disappointed with both and exited after a yr, long enough period to show some gains. They both gave only 6-8% at the end of the yr.

So friends, pharma cos make lot of money but don't reward the share holders..keep in mind they will give only low returns

Best regards

Thanx.. I will remember your suggestion.

Regards,
Luckytrader